View this trio of interactive videos featuring expert discussion on treating and preventing invasive fungal infections such as candidiasis, aspergillosis, and mucormycosis. Then download the accompanying slidesets for your own review.
This interactive video module reviews the epidemiology and outcomes trends for IFI in high-risk patients, guideline recommendations for primary antifungal therapy, and the advantages and disadvantages of current treatment options.
This interactive video module examines risk stratification, nonpharmacologic strategies to reduce fungal exposure, guideline recommendations for prophylactic therapy, and management of breakthrough infections.
This interactive video module highlights areas of unmet medical need in the prevention and treatment of IFIs as well as ongoing efforts to address these barriers including new uses for established agents and the development of novel agents with unique mechanisms of action.
Review guideline recommendations for primary antifungal therapy in high-risk patients as well as the benefits and risks of specific agents.
Learn to risk stratify patients, select optimal prophylactic therapy, and manage breakthrough fungal infections with this downloadable slideset.
Gain insight on strategies under investigation to address barriers to effective prevention and treatment of invasive fungal infections. Learn about new uses for existing agents, new agents in currently used classes, and new compounds with unique mechanisms of action.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.